Filing Details

Accession Number:
0000897069-24-000395
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-15 16:11:13
Reporting Period:
2024-02-13
Accepted Time:
2024-02-15 16:11:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1971532 Telomir Pharmaceuticals Inc. TELO Pharmaceutical Preparations (2834) 872606031
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1986593 Trust Shore Bay C/O Telomir Pharmaceuticals, Inc.
900 West Platt Street, Suite 200
Tampa FL 33606
No No No No
1996353 Patrick Brian Mcnulty C/O Telomir Pharmaceuticals, Inc.
900 West Platt Street, Suite 200
Tampa FL 33606
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-13 49,000 $7.00 5,455,431 No 4 P Indirect By Trust
Common Stock Acquisiton 2024-02-13 40,000 $7.00 1,365,646 No 4 P Indirect See Footnote
Common Stock Acquisiton 2024-02-13 49,000 $7.00 1,902,659 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect See Footnote
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,391 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Common Stock (right to buy) $3.73 2023-06-15 2028-06-15 2,439,025 2,439,025 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-06-15 2,439,025 2,439,025 Indirect
Footnotes
  1. These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  2. These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  3. These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
  4. These securities are owned directly by Mr. McNulty.